37 results
8-K
EX-10.2
MIST
Milestone Pharmaceuticals Inc
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
EX-10.1
MIST
Milestone Pharmaceuticals Inc
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
EX-10.1
5ltvuo57qnwjtr7
27 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
u6fydb5w8tx87a0d
16 Feb 22
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer
7:37am
8-K
EX-10.1
6kzuv
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
5795sjd7xwa72ur3vx6m
23 Jul 20
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
7:05am
8-K
EX-10.3
02yko75l
9 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
kpl46bmjc4aqct lti3u
9 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
x8e37ri4
9 Jun 20
Departure of Directors or Certain Officers
12:00am